No channels found
  1. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    10
  2. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    11
  3. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  4. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    2
  5. Breaking News | Soligenix, Inc. (Nasdaq: SNGX) | RICH TV LIVE PODCAST

    Breaking News | Soligenix, Inc. (Nasdaq: SNGX) | RICH TV LIVE PODCAST

    64
  6. September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    21
  7. May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    9
  8. Inside Soligenix: Innovations in Rare Disease Therapies

    Inside Soligenix: Innovations in Rare Disease Therapies

    1
  9. Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

    Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

  10. Soligenix: Illuminating the Future of Rare Disease Therapies

    Soligenix: Illuminating the Future of Rare Disease Therapies

    5